Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules

Kieran D. Lamb, Martha M. Luka, Megan Saathoff, Richard J. Orton, My V. T. Phan, Matthew Cotten, Ke Yuan, David L. Robertson. Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules. PLoS Computational Biology, 20(1), January 2024. [doi]

Abstract

Abstract is missing.